glp 1 agonists and muscle loss Balancing weight in GLP1 receptor agonist therapy Glucagon-like peptide-1 receptor agonists and
Description
Explore the mechanisms, clinical applications, and future opportunities of GLP-1 receptor agonists in drug development and disease management.

7.40.8 Eq/min/gkw)
GLP-1 medications and low blood pressure: Learn how semaglutide, tirzepatide, and other GLP-1 drugs affect blood pressure, recognize hypotension symptoms, and discover essential management strategies to stay safe during treatment.

A new case series presents a unique paradox where GLP-1 RA therapy improved quality of life and resolved diarrhea in two women with

Preclinical and initial human studies suggest that glucagon-like peptide-1 receptor agonists may be promising treatments for alcohol use disorder, but existing approved treatments should be used until safety and efficacy is demonstrated in clinical trials.

Glucagon-like peptide-1 (GLP-1) is one of the incretins that regulate glucose metabolism
